HDAC1 and acute myeloid leukemia: Leukemic transformation occurs in 1%, 4%, and 20% of patients over a 10-year period in ET, PV, and PMF, respectively.25 When we analyzed data from 150 AML patients from the TCGA database, we found that patients with higher HDAC1 expression had poorer survival rates (Fig. 2k).